Anterix (ATEX) Projected to Post Earnings on Wednesday

Anterix (NASDAQ:ATEX) is anticipated to release its Q3 2026 results after the market closes on Wednesday, February 11th. Analysts expect the company to announce earnings of ($0.57) per share and revenue of $1.4680 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Thursday, February 12, 2026 at 9:00 AM ET.

Anterix (NASDAQ:ATEX) last issued its quarterly earnings results on Wednesday, November 12th. The company reported ($0.14) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.51. The business had revenue of $1.55 million for the quarter, compared to analyst estimates of $1.43 million. Anterix had a negative return on equity of 14.95% and a net margin of 1,614.08%. On average, analysts expect Anterix to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Anterix Stock Up 1.1%

Shares of Anterix stock opened at $28.70 on Tuesday. The company has a 50 day moving average price of $23.36 and a 200 day moving average price of $21.99. The firm has a market capitalization of $537.26 million, a P/E ratio of 5.62 and a beta of 0.86. Anterix has a 52 week low of $17.58 and a 52 week high of $42.91.

Insider Buying and Selling at Anterix

In other Anterix news, insider Gena L. Ashe sold 6,564 shares of Anterix stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $21.07, for a total value of $138,303.48. Following the completion of the transaction, the insider owned 13,366 shares of the company’s stock, valued at approximately $281,621.62. The trade was a 32.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Scott A. Lang bought 1,160 shares of the stock in a transaction dated Thursday, December 18th. The shares were purchased at an average cost of $21.61 per share, for a total transaction of $25,067.60. Following the completion of the purchase, the chief executive officer owned 8,260 shares in the company, valued at approximately $178,498.60. This represents a 16.34% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 45.61% of the stock is currently owned by company insiders.

Institutional Trading of Anterix

Institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC increased its position in shares of Anterix by 16.9% in the first quarter. AQR Capital Management LLC now owns 11,489 shares of the company’s stock valued at $420,000 after buying an additional 1,659 shares in the last quarter. Millennium Management LLC grew its stake in Anterix by 50.6% in the 1st quarter. Millennium Management LLC now owns 116,473 shares of the company’s stock valued at $4,263,000 after acquiring an additional 39,143 shares during the period. Goldman Sachs Group Inc. increased its holdings in Anterix by 17.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 124,706 shares of the company’s stock worth $4,564,000 after acquiring an additional 18,771 shares in the last quarter. Legal & General Group Plc increased its holdings in Anterix by 19.7% in the 2nd quarter. Legal & General Group Plc now owns 11,303 shares of the company’s stock worth $290,000 after acquiring an additional 1,857 shares in the last quarter. Finally, Rhumbline Advisers raised its position in Anterix by 70.9% during the second quarter. Rhumbline Advisers now owns 27,998 shares of the company’s stock worth $718,000 after acquiring an additional 11,615 shares during the period. 87.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently commented on ATEX. Zacks Research downgraded shares of Anterix from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. reduced their target price on Anterix from $67.00 to $50.00 and set an “overweight” rating for the company in a research note on Friday, October 17th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Anterix in a research note on Wednesday, January 21st. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Anterix presently has an average rating of “Hold” and an average price target of $50.00.

Anterix Company Profile

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.